John Michael Maslowski
Genetherapy
Fibrocell Science
United States of America
Biography
Mr. John Michael Maslowski has been the Chief Executive Officer of Fibrocell Science, Inc. since December 19, 2016 and serves as its President. Mr. Maslowski has been Principal Financial Officer & Principal Accounting Officer at Fibrocell Science, Inc. since June 22, 2017. Mr. Maslowski served as Senior Vice President of Scientific Affairs at Fibrocell Science, Inc. (formerly Isolagen, Inc) from September 14, 2015 to December 19, 2016. Mr. Maslowski served as Vice President of Scientific Affairs of Fibrocell Science until September 14, 2015 and served as its Vice President of Operations - Scientific Affairs. He served as Vice President of Operations of Fibrocell Science, Inc. (formerly Isolagen, Inc.) since March 2008. He joined Fibrocell Science, Inc. (formerly Isolagen, Inc.) in 2005 and held various management positions in Manufacturing and Quality Assurance. He served as Senior Director of Operations of Fibrocell Science, Inc. Prior to Isolagen, Mr. Maslowski served as Quality Assurance Investigations Manager in support of manufacturing of Wyeth Pharmaceuticals. He has been a Director of Fibrocell Science, Inc. since March 2013. He worked at Wyeth Pharmaceuticals from 2001 to 2005. Previously, he held positions with Merck Research Laboratories and Teva Pharmaceuticals. Mr. Maslowski holds a BS in Biology from Ursinus College and MS in Biology from Villanova University. He is a Certified Quality Auditor through the American Society for Quality.
Research Interest
business